Shiloh
Editor, Senior Moderator
Source: https://www.cidrap.umn.edu/news-per...xtends-moratorium-booster-covid-vaccine-doses
WHO extends moratorium on booster COVID vaccine doses
Filed Under:
COVID-19
Lisa Schnirring | News Editor | CIDRAP News
| Sep 08, 2021
At a briefing today, the head of the World Health Organization (WHO) called for a global moratorium on COVID-19 vaccine booster doses to be extended until the end of the year to allow more people in low- and middle-income countries to be vaccinated.
In other developments, the WHO's weekly snapshot of the pandemic shows that global cases and deaths remain at a high plateau, with the Americas standing out as one of the main hot spots.
Vaccine deliveries fall short
WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said today at the briefing that high-income countries have pledged 1 billion doses, but less than 15% of the promised supply has materialized.
The supply picture hasn't changed much since August, when the WHO first called for the booster dose moratorium until the end of September, Tedros said. He called for an extension until the end of the year to allow all countries to vaccinate at least 40% of their populations.
"Manufacturers have promised to prioritize COVAX and low-income countries," Tedros said, adding, "We don't want any more promises. We just want the vaccines."
Tedros pointed to a statement yesterday from the International Federation of Pharmaceutical Manufacturers Association (IFPMA), which said G7 countries now have enough vaccine for all adults and teens, as well as for booster doses for at-risk groups, and that scale-up now should shift to global vaccine equity and dose sharing.
The IFPMA said international production will reach 7.5 billion doses by the end of September, adding nearly 1.5 billion doses each month. And that by January, there will be enough for every adult on every continent.
He countered that manufacturers and high-income countries have long had the capacity to vaccinate their priority groups while supporting immunization of the same groups throughout the world.
COVAX falls short of target
In related vaccine developments, the WHO and its COVAX partners—the Coalition for Epidemic Preparedness Innovations and Gavi—today released vaccine supply forecasts for 2021 and early 2022.
They expect COVAX doses to reach 1.425 billion in 2021, of which 1.2 billion will be available to lower-income countries. The amount is enough to cover 20% of country populations, or 40% of all adults.
The groups said the total won't reach the 2-billion-dose milestone that it had hoped to deliver in 2021 until the first quarter of 2022.
Though COVAX has made significant progress, with 240 million doses delivered to 139 countries in just 6 months, they said the global picture is still unacceptable. Only 20% of people in lower- and middle-income countries have received their first doses, compared with 80% in higher-income countries.
Weekly epi update
In its weekly situation update, the WHO said 4.4 million COVID cases were reported last week, marking a stable pattern at a very high level. All regions saw declining or stable cases, except for the Americas, where cases rose 19% over the previous week.
Deaths remained steady globally, too, but they were up by 17% in the Americas and 20% in Europe.
The United States, again one of the world's main hot spots, led the world with the most new cases last week, followed by India, the United Kingdom, Iran, and Brazil.
Four more countries reported their first Delta (B1617.2) variant detections, putting the total at 174.
More global headlines
WHO extends moratorium on booster COVID vaccine doses
Filed Under:
COVID-19
Lisa Schnirring | News Editor | CIDRAP News
| Sep 08, 2021
At a briefing today, the head of the World Health Organization (WHO) called for a global moratorium on COVID-19 vaccine booster doses to be extended until the end of the year to allow more people in low- and middle-income countries to be vaccinated.
In other developments, the WHO's weekly snapshot of the pandemic shows that global cases and deaths remain at a high plateau, with the Americas standing out as one of the main hot spots.
Vaccine deliveries fall short
WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said today at the briefing that high-income countries have pledged 1 billion doses, but less than 15% of the promised supply has materialized.
The supply picture hasn't changed much since August, when the WHO first called for the booster dose moratorium until the end of September, Tedros said. He called for an extension until the end of the year to allow all countries to vaccinate at least 40% of their populations.
"Manufacturers have promised to prioritize COVAX and low-income countries," Tedros said, adding, "We don't want any more promises. We just want the vaccines."
Tedros pointed to a statement yesterday from the International Federation of Pharmaceutical Manufacturers Association (IFPMA), which said G7 countries now have enough vaccine for all adults and teens, as well as for booster doses for at-risk groups, and that scale-up now should shift to global vaccine equity and dose sharing.
The IFPMA said international production will reach 7.5 billion doses by the end of September, adding nearly 1.5 billion doses each month. And that by January, there will be enough for every adult on every continent.
He countered that manufacturers and high-income countries have long had the capacity to vaccinate their priority groups while supporting immunization of the same groups throughout the world.
COVAX falls short of target
In related vaccine developments, the WHO and its COVAX partners—the Coalition for Epidemic Preparedness Innovations and Gavi—today released vaccine supply forecasts for 2021 and early 2022.
They expect COVAX doses to reach 1.425 billion in 2021, of which 1.2 billion will be available to lower-income countries. The amount is enough to cover 20% of country populations, or 40% of all adults.
The groups said the total won't reach the 2-billion-dose milestone that it had hoped to deliver in 2021 until the first quarter of 2022.
Though COVAX has made significant progress, with 240 million doses delivered to 139 countries in just 6 months, they said the global picture is still unacceptable. Only 20% of people in lower- and middle-income countries have received their first doses, compared with 80% in higher-income countries.
Weekly epi update
In its weekly situation update, the WHO said 4.4 million COVID cases were reported last week, marking a stable pattern at a very high level. All regions saw declining or stable cases, except for the Americas, where cases rose 19% over the previous week.
Deaths remained steady globally, too, but they were up by 17% in the Americas and 20% in Europe.
The United States, again one of the world's main hot spots, led the world with the most new cases last week, followed by India, the United Kingdom, Iran, and Brazil.
Four more countries reported their first Delta (B1617.2) variant detections, putting the total at 174.
More global headlines
- The pandemic has had devastating impacts on battles against HIV, tuberculosis (TB), and malaria in 2020, the Global Fund said today in a new report. Though progress was made in some areas, key programs declined for the first time in the Global Fund's 20-year history. For example, the number of people treated for drug-resistant TB fell by 19% in countries supported by Global Fund programs, with treatment for extensively drug-resistant TB declining 37%.
- The International Monetary Fund yesterday approved $567 million in emergency financial assistance for Tanzania, which has experienced the collapse of its tourism sector and needs to implement a pandemic plan in an effort to stabilize the economy.
- South Korea's government is working on a plan to live more normally with COVID-19, once 80% of adults are fully vaccinated by late October, according to Reuters. The country is experiencing its worst surge, but has kept severe cases in check by increasing vaccinations.
- The global total today climbed to 222,286,189 cases, and 4,592,304 people have died from their infections, according to the Johns Hopkins online dashboard.